ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 102 filers reported holding ARATANA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $344,000 | +53.6% | 66,578 | +6.9% | 0.00% | – |
| Q1 2019 | $224,000 | -40.7% | 62,288 | +1.1% | 0.00% | -100.0% |
| Q4 2018 | $378,000 | +56.8% | 61,611 | +49.2% | 0.00% | – |
| Q3 2018 | $241,000 | +33.9% | 41,285 | -2.5% | 0.00% | – |
| Q2 2018 | $180,000 | +13.2% | 42,350 | +17.3% | 0.00% | – |
| Q1 2018 | $159,000 | -18.9% | 36,090 | -3.0% | 0.00% | – |
| Q4 2017 | $196,000 | -34.4% | 37,190 | -23.6% | 0.00% | -100.0% |
| Q3 2017 | $299,000 | -14.3% | 48,704 | +1.0% | 0.00% | 0.0% |
| Q2 2017 | $349,000 | +59.4% | 48,214 | +16.4% | 0.00% | 0.0% |
| Q1 2017 | $219,000 | -11.3% | 41,414 | +20.4% | 0.00% | 0.0% |
| Q4 2016 | $247,000 | -23.3% | 34,387 | -0.2% | 0.00% | 0.0% |
| Q3 2016 | $322,000 | +53.3% | 34,449 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $210,000 | +19.3% | 33,189 | +4.1% | 0.00% | 0.0% |
| Q1 2016 | $176,000 | 0.0% | 31,874 | +1.0% | 0.00% | 0.0% |
| Q4 2015 | $176,000 | -23.1% | 31,564 | +16.7% | 0.00% | 0.0% |
| Q3 2015 | $229,000 | -41.9% | 27,049 | +3.9% | 0.00% | 0.0% |
| Q2 2015 | $394,000 | -6.2% | 26,035 | -0.8% | 0.00% | 0.0% |
| Q1 2015 | $420,000 | +14.1% | 26,240 | +27.1% | 0.00% | 0.0% |
| Q4 2014 | $368,000 | +97.8% | 20,640 | +11.5% | 0.00% | 0.0% |
| Q3 2014 | $186,000 | -35.6% | 18,515 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $289,000 | – | 18,515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|